Physician
Crown City Medical Group, INC.
Crown City Medical Group, INC. was paid $453K by Medicaid between Jan 2018 and Jul 2021, across 128 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoCROWN CITY MEDICAL GROUP, INC.
PASADENA, CA 91107
PASADENA, CA 91107
33aNPI1073512836assigned 07/14/2005
33bProvider typeFamily Medicine Physician
28Total paid$453K
24GClaims307,163
24DCodes billed128
24AFirst – last monthJan 2018 – Jul 2021
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#275 of 2,511
Median peer was paid$13K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 111,130 | $123K | |
| 2019 | 104,324 | $243K | |
| 2020 | 62,930 | $56K | |
| 2021 | 28,779 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 37,520 | 34,652 | $137K |
| 97802 | 12% | 14,558 | 14,526 | $54K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.5% | 3,423 | 3,405 | $34K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 2,701 | 2,672 | $34K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.3% | 3,635 | 3,621 | $29K |
| 90651 | 6.3% | 2,126 | 2,126 | $28K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.1% | 4,178 | 4,051 | $18K |
| 92551 | 3.6% | 9,617 | 9,611 | $16K | |
| 96151 | 2.2% | 7,147 | 7,147 | $10K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 385 | 370 | $9K |
| 90686 | 2.0% | 4,391 | 4,387 | $9K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.9% | 1,246 | 1,243 | $9K |
116 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 315 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 2,633 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 696 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.1% | 1,318 | $5K |
| 97803 | <1% | 602 | $4K | |
| 90670 | <1% | 1,088 | $3K | |
| 90648 | <1% | 1,054 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 5,210 | $3K |
| 99000 | <1% | 9,206 | $3K | |
| 85018 | <1% | 11,260 | $3K | |
| 90734 | <1% | 1,592 | $2K | |
| 81002 | <1% | 10,077 | $2K | |
| 90723 | <1% | 490 | $2K | |
| 90633 | <1% | 604 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 26 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 740 | $1K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 686 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,109 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,691 | $1K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 67 | $864.05 |
| 90715 | <1% | 474 | $729.66 | |
| 93000 | <1% | 319 | $700.44 | |
| 3008F | <1% | 48,013 | $643.50 | |
| 90620 | <1% | 618 | $636.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 401 | $610.92 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,845 | $570.80 |
| 96150 | <1% | 631 | $554.34 | |
| 86580 | <1% | 564 | $515.02 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 98 | $441.18 |
| 99381 | <1% | 15 | $359.04 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,279 | $333.44 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 18 | $263.43 |
| 90710 | <1% | 139 | $262.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14 | $257.35 |
| 86592 | <1% | 423 | $249.54 | |
| 3074F | <1% | 15,695 | $218.40 | |
| 3078F | <1% | 15,190 | $212.10 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 30 | $205.66 |
| 90716 | <1% | 51 | $199.00 | |
| 90696 | <1% | 107 | $183.00 | |
| 83655 | <1% | 278 | $178.84 | |
| 80053 | Comprehensive metabolic panel | <1% | 905 | $176.38 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 16 | $175.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 947 | $128.08 |
| 90698 | <1% | 29 | $99.00 | |
| 90681 | <1% | 24 | $99.00 | |
| 4120F | <1% | 7,893 | $94.20 | |
| A4649 | Surgical supply; miscellaneous | <1% | 47 | $69.39 |
| 90707 | <1% | 37 | $65.00 | |
| 90461 | <1% | 1,824 | $62.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 85 | $60.00 |
| 90700 | <1% | 41 | $55.00 | |
| 90744 | <1% | 13 | $54.00 | |
| 81025 | <1% | 380 | $49.64 | |
| 3352F | <1% | 2,575 | $46.80 | |
| 99441 | <1% | 10,673 | $41.04 | |
| 90656 | <1% | 120 | $36.00 | |
| 99173 | <1% | 13,243 | $31.08 | |
| 3351F | <1% | 1,057 | $28.50 | |
| G0008 | Administration of influenza virus vaccine | <1% | 486 | $19.00 |
| 99442 | <1% | 1,364 | $18.86 | |
| 3079F | <1% | 2,239 | $17.70 | |
| 3725F | <1% | 401 | $14.70 | |
| 82947 | <1% | 431 | $12.42 | |
| 3044F | <1% | 708 | $12.00 | |
| 96127 | <1% | 156 | $9.52 | |
| 80061 | Lipid panel | <1% | 1,033 | $8.83 |
| 3075F | <1% | 1,033 | $6.30 | |
| 3048F | <1% | 232 | $3.90 | |
| 3353F | <1% | 347 | $3.30 | |
| 1220F | <1% | 334 | $2.70 | |
| 3077F | <1% | 698 | $2.40 | |
| 4010F | <1% | 341 | $0.90 | |
| 3050F | <1% | 131 | $0.60 | |
| 1170F | <1% | 155 | $0.30 | |
| 3080F | <1% | 280 | $0.30 | |
| 1157F | <1% | 33 | $0.30 | |
| 3015F | <1% | 189 | $0.30 | |
| 1160F | <1% | 332 | $0.30 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 357 | $0.00 |
| 86695 | 0% | 75 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 726 | $0.00 |
| 96156 | 0% | 1,809 | $0.00 | |
| 3049F | 0% | 171 | $0.00 | |
| 81001 | 0% | 375 | $0.00 | |
| 99156 | 0% | 34 | $0.00 | |
| 1036F | 0% | 704 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 854 | $0.00 |
| 87070 | 0% | 16 | $0.00 | |
| 1126F | 0% | 191 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 756 | $0.00 |
| 1000F | 0% | 76 | $0.00 | |
| 57410 | 0% | 86 | $0.00 | |
| 3017F | 0% | 12 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 15 | $0.00 |
| 4140F | 0% | 24 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 184 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 27 | $0.00 |
| 1125F | 0% | 76 | $0.00 | |
| 20553 | 0% | 13 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 13 | $0.00 |
| 84436 | 0% | 14 | $0.00 | |
| 3354F | 0% | 12 | $0.00 | |
| 96160 | 0% | 9,137 | $0.00 | |
| 92552 | 0% | 15 | $0.00 | |
| 84439 | 0% | 132 | $0.00 | |
| 1159F | 0% | 397 | $0.00 | |
| 4124F | 0% | 143 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 26 | $0.00 |
| 86696 | 0% | 74 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 65 | $0.00 |
| 1158F | 0% | 25 | $0.00 | |
| 82565 | 0% | 12 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 64 | $0.00 |
| 84520 | 0% | 12 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTYSON, KEVIN (MIDICAL DIRECTOR)